BIONET TX Corp

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

105

Website

www.bionettx.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2022

BIONET Therapeutics Corp., a biopharmaceutical company develops cell therapy products and drug development for acute and severe diseases. The company develops treatment for adult respiratory distress syndrome, pulmonary fibrosis, chronic kidney disease, acute wound healing, chronic wound healing of diabetic ulcers, and osteoarthritis CRDMO services. Founded in 2022, the company is based in Taipei, Taiwan.

Key Stats

52-Week Range

NT$28.55NT$66.30

BetaN/A

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-1.39

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.